Bixel, K., Vetter, M., Davidson, B., Berchuck, A., Cohn, D., Copeland, L., . . . Backes, F. (2020). Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer. Gynecologic Oncology, 156(3), 530. https://doi.org/10.1016/j.ygyno.2019.12.016
Chicago Style (17th ed.) CitationBixel, K., et al. "Intraperitoneal Chemotherapy Following Neoadjuvant Chemotherapy and Optimal Interval Tumor Reductive Surgery for Advanced Ovarian Cancer." Gynecologic Oncology 156, no. 3 (2020): 530. https://doi.org/10.1016/j.ygyno.2019.12.016.
MLA (9th ed.) CitationBixel, K., et al. "Intraperitoneal Chemotherapy Following Neoadjuvant Chemotherapy and Optimal Interval Tumor Reductive Surgery for Advanced Ovarian Cancer." Gynecologic Oncology, vol. 156, no. 3, 2020, p. 530, https://doi.org/10.1016/j.ygyno.2019.12.016.